Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-10T12:53:16.509Z Has data issue: false hasContentIssue false

Compliance Therapy: An Intervention Targeting Insight and Treatment Adherence in Psychotic Patients

Published online by Cambridge University Press:  16 June 2009

Roisin Kemp
Affiliation:
King's College Hospital & Institute of Psychiatry, London
Anthony David
Affiliation:
King's College Hospital & Institute of Psychiatry, London
Peter Hayward
Affiliation:
Maudsley Hospital & Institute of Psychiatry, London

Extract

A randomized controlled trial of a new intervention based on motivational interviewing and cognitive approaches to psychosis (Compliance Therapy) has shown improvements in insight, attitudes to medication and compliance in an unselected sample of consecutively admitted patients with acute psychotic disorders. In the introduction, previous research focusing on cognitive interventions in psychosis and systematically tested psychoeducational approaches to compliance are reviewed. The content of our intervention is described with examples of the principal techniques used, together with a description of the progress of therapy in two individual cases. We conclude that the intervention is eminently applicable in the typical clinical setting.

Type
Main Section
Copyright
Copyright © British Association for Behavioural and Cognitive Psychotherapies 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, S.G. and Howe, J.T. (1993). Predicting medication compliance in a psychotic population. Journal of Nervous and Mental Disease 181, 558560.CrossRefGoogle Scholar
Alford, B.A. and Correia, C.J. (1994). Cognitive therapy of schizophrenia: theory and empirical status. Behaviour Therapy 25, 1733.CrossRefGoogle Scholar
Babiker, I.E. (1986). Noncompliance in schizophrenia. Psychiatric Developments 4, 329337.Google ScholarPubMed
Bebbington, P.E. (1995). The content and context of compliance. International Clinical Psychopharmacology 9 (suppl 5), 4150.CrossRefGoogle ScholarPubMed
Blackwell, B. (1992). Compliance. Psychotherapy and Psychosomatics 58, 161169.CrossRefGoogle ScholarPubMed
Boczkowski, J.A., Zeichner, A. and DeSanto, N. (1985). Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. Journal of Consulting and Clinical Psychology 53(5), 666671.CrossRefGoogle ScholarPubMed
Brown, C., Wright, R. and Christensen, D. (1987). Association between type of medication instruction and patient knowledge, side effects and compliance. Hospital and Community Psychiatry 34, 934938.Google Scholar
Corrigan, P.W., Liberman, R.P. and Engel, J.D. (1990). From noncompliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry 41, 12031211.Google ScholarPubMed
David, A.S. (1990). Insight and psychosis. British Journal of Psychiatry 156, 798808.CrossRefGoogle ScholarPubMed
Diamond, R.J. (1983). Enhancing medication use in schizophrenic patients. Journal of Clinical Psychiatry 44, 714.Google ScholarPubMed
Eckman, T.A., Liberman, R.P., Phipps, C.C. and Blair, K. (1990). Teaching medication management skills to schizophrenic patients. Journal of Clinical Psychopharmacology 10, 3338.CrossRefGoogle ScholarPubMed
Eckman, T.A., Wirshing, W.C., Marder, S.R., Liberman, R.P., Jonston-Cronk, K., Zimmerman, K. and Mintz, J. (1992). Technique for training patients in illness self-management: a controlled trial. American Journal of Psychiatry 149, 15491555.Google ScholarPubMed
Falloon, I.R.H. (1984). Developing and maintaining adherence to long-term drug-taking regimens. Schizophrenia Bulletin 10, 15491555.CrossRefGoogle ScholarPubMed
Fowler, D., Garety, P. and Kuipers, E. (1995). Cognitive behaviour therapy for psychosis. Chichester: Wiley.Google Scholar
Garety, P.A., Kuipers, L., Fowler, D., Chamberlain, F. and Dunn, G. (1994). Cognitive behavioural therapy for drug-resistant psychosis. British Journal of Medical Psychology 67, 259271.CrossRefGoogle ScholarPubMed
Goldstein, M.J. (1992). Psychosocial strategies for maximizing the effects of psychotropic medications for schizophrenia and mood disorder. Psychopharmacology Bulletin 28, 237240.Google ScholarPubMed
Gordis, L. (1979). Conceptual and methodologic problems in measuring patient compliance. In Haynes, R.B., Taylor, D.W. and Sackett, D.L. (Eds). Compliance in health care. Baltimore: Johns Hopkins University Press.Google Scholar
Hawton, K., Salkovskis, P.M., Kirk, J. and Clark, D.M. (1989). Cognitive behaviour therapy for psychiatric problems: a practical guide. Oxford: Oxford University Press.Google Scholar
Hayward, P., Chan, N., Kemp, R., Youle, S. and David, A. (1995). Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health 4, 513519.CrossRefGoogle Scholar
Hogan, T.P., Awad, A.G. and Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: reliability and predictive validity. Psychological Medicine 13, 177183.CrossRefGoogle Scholar
Kane, J.M. (1983). Problems of compliance in the outpatient treatment of schizophrenia. Journal of Clinical Psychiatry 44, 36.Google ScholarPubMed
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B. and David, A. (1996). Compliance therapy in psychotic patients: a randomized controlled trial. British Medical Journal 312, 345349.CrossRefGoogle Scholar
Kemp, R. and David, A. (1995). Insight and adherence to treatment in psychotic disorders. British Journal of Hospital Medicine 54, 222227.Google ScholarPubMed
Kemp, R. and David, A. (in press). Insight and compliance. In Blackwell, B. (Ed). Compliance and the treatment alliance in serious mental illness. Newark, NJ: Gordon and Breach Publishing Group.Google Scholar
Kemp, R. and David, A. (1996). Psychological predictors of insight and compliance in psychotic patients. British Journal of Psychiatry 169, 444450.CrossRefGoogle ScholarPubMed
Kingdon, D.G. and Turkington, D. (1991). Preliminary report. The use of cognitive behaviour therapy and a normalizing rationale in schizophrenia. Journal of Nervous and Mental Disease 179, 207211.CrossRefGoogle Scholar
Kingdon, D.G. and Turkington, D. (1994). Cognitive-behavioural therapy of schizophrenia. New York: Guilford Press.Google ScholarPubMed
Kingdon, D., Turkington, D. and John, C. (1994). Cognitive behaviour therapy of schizophrenia. British Journal of Psychiatry 164, 581587.CrossRefGoogle ScholarPubMed
Kissling, W. (1994). Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatrica Scandinavica 89 (suppl 382), 1624.CrossRefGoogle Scholar
Lyon, H.M., Kaney, S. and Bentall, R.P. (1994). The defensive function of persecutory delusions: Evidence from attribution tasks. British journal of Psychiatry 164, 637646.CrossRefGoogle ScholarPubMed
Lukoff, D., Liberman, R.P. and Neuchterlein, K.H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin 12, 578602.CrossRefGoogle ScholarPubMed
McEvoy, J.P., Freter, S., Everett, G., Geller, G.L., Appelbaum, P., Apperson, L.J. and Roth, L. (1989). Insight and the clinical outcome of schizophrenic patients. Journal of Nervous and Mental Disease 177, 4851.CrossRefGoogle ScholarPubMed
McEvoy, J.P., Hogarty, G.E. and Steingard, S. (1991). Optimal dose of neuroleptic medication in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry 48, 739745.CrossRefGoogle ScholarPubMed
Miller, W.R. and Rollnick, S. (1991). Motivational interviewing: preparing people to change. New York: Guilford Press.Google Scholar
Perris, C. (1989). Cognitive therapy with schizophrenic patients. New York: Guilford Press.Google Scholar
Rollnick, S., Heather, N. and Bell, A. (1992). Negotiating behaviour change in medical settings: the development of brief motivational interviewing. Journal of Mental Health 1, 2537.CrossRefGoogle Scholar
Seltzer, A., Roncari, I. and Garfinkel, P. (1980). Effect of patient education on medication compliance. American Journal of Psychiatry 25, 638645.Google ScholarPubMed
Smith, J., Birchwood, M. and Haddrell, A. (1992). Informing people with schizophrenia about their illness: the effect of residual symptoms. Journal of Mental Health 1, 6170.CrossRefGoogle Scholar
Streicker, S.K., Amdur, M. and Dincin, J. (1986). Educating patients about psychiatric medications: failure to enhance compliance. Psychosocial Rehabilitation Journal 4, 1528.CrossRefGoogle Scholar
Tarrier, N., Beckett, R., Harwood, S., Baker, S., Yusupoff, L. and Ugarteburu, I. (1993a). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry 162, 524532.CrossRefGoogle Scholar
Tarrier, N., Sharpe, L., Beckett, R., Harwood, S., Baker, A. and Yusopoff, L. (1993b). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: 11. Treatment-specific changes in coping and problem-solving skills. Social Psychiatry and Psychiatric Epidemiology 28, 510.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.